Cargando…

Current and emerging biological therapy in adult-onset Still’s disease

Adult-onset Still’s disease (AOSD) is a rare, but characteristic non-familial, multi-genic systemic auto-inflammatory disorder, characterized by high spiking fever, salmon-like evanescent skin rash, polyarthritis, sore throat, hyperferritinemia and leucocytosis. The hallmark of AOSD is a cytokine st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yuning, Meng, Jianfen, Jia, Jinchao, Wang, Mengyan, Teng, Jialin, Zhu, Dehao, Yang, Chengde, Hu, Qiongyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410009/ https://www.ncbi.nlm.nih.gov/pubmed/34117886 http://dx.doi.org/10.1093/rheumatology/keab485

Ejemplares similares

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
por: Meng, Jianfen, et al.
Publicado: (2021)

Association of the Leukocyte Immunoglobulin‐like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult‐Onset Still’s Disease
por: Wang, Mengyan, et al.
Publicado: (2021)

Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still’s disease pathogenesis
por: Jia, Jinchao, et al.
Publicado: (2022)

Circulating Neutrophil Extracellular Traps Signature for Identifying Organ Involvement and Response to Glucocorticoid in Adult-Onset Still’s Disease: A Machine Learning Study
por: Jia, Jinchao, et al.
Publicado: (2020)

Neutrophil-derived lipocalin-2 in adult-onset Still’s disease: a novel biomarker of disease activity and liver damage
por: Jia, Jinchao, et al.
Publicado: (2020)

Cytomegalovirus Infection May Trigger Adult-Onset Still's Disease Onset or Relapses
por: Jia, Jinchao, et al.
Publicado: (2019)

Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China
por: Hu, Qiongyi, et al.
Publicado: (2020)

A Cohort Study of Liver Involvement in Patients With Adult-Onset Still's Disease: Prevalence, Characteristics and Impact on Prognosis
por: Chi, Huihui, et al.
Publicado: (2020)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease
por: Sun, Yue, et al.
Publicado: (2020)

Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still’s disease
por: Hu, Qiongyi, et al.
Publicado: (2019)

Pregnancy Outcomes in Patients With Adult-Onset Still's Disease: A Cohort Study From China
por: Wang, Zhihong, et al.
Publicado: (2020)

Serum sTREM-1 in adult-onset Still’s disease: a novel biomarker of disease activity and a potential predictor of the chronic course
por: Wang, Zhihong, et al.
Publicado: (2020)

Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity
por: Chi, Huihui, et al.
Publicado: (2018)

COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study
por: Pan, Haoyu, et al.
Publicado: (2022)

Total metabolic lesion volume of lymph nodes measured by (18)F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease
por: Wan, Liyan, et al.
Publicado: (2021)

Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis
por: Hu, Qiongyi, et al.
Publicado: (2019)

Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease
por: Su, Yutong, et al.
Publicado: (2019)

Methylenetetrahydrofolate Reductase 677T Allele Is a Risk Factor for Arterial Thrombosis in Chinese Han Patients with Antiphospholipid Syndrome
por: Tang, Zihan, et al.
Publicado: (2022)

Differential diagnostic performance of PET/CT in adult-onset still’s disease and lymphoma: a retrospective pilot study
por: Wan, Liyan, et al.
Publicado: (2022)

Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still’s Disease From Sepsis
por: Tian, Rui, et al.
Publicado: (2021)

Delayed-onset of progressive pseudorheumatoid dysplasia in a Chinese adult with a novel compound WISP3 mutation: a case report
por: Hu, Qiongyi, et al.
Publicado: (2017)

Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases
por: Teng, Jialin, et al.
Publicado: (2020)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2017)

Progress in Biological Therapies for Adult-Onset Still’s Disease
por: Galozzi, Paola, et al.
Publicado: (2022)

Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2018)

Adult-onset Still’s disease: current challenges and future prospects
por: Siddiqui, Mariam, et al.
Publicado: (2016)

Adult-Onset Still’s Disease
por: Mitrovic, Stéphane, et al.
Publicado: (2019)

Adult-Onset Still’s Disease
por: Efthimiou, Petros, et al.
Publicado: (2018)

Both HLA class I and II regions identified as genome-wide significant susceptibility loci for adult-onset Still's disease in Chinese individuals
por: Li, Zhiqiang, et al.
Publicado: (2020)

Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review
por: Wang, Meng-Yan, et al.
Publicado: (2019)

Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Adult Onset Still's Disease and Autoinflammation
por: Efthimiou, Petros, et al.
Publicado: (2012)

Myocarditis in Adult-Onset Still Disease
por: Gerfaud-Valentin, Mathieu, et al.
Publicado: (2014)

Refractory Adult Onset Still’s Disease
por: Sulaiman, Wahinuddin, et al.
Publicado: (2017)

Elderly-onset adult Still’s disease
por: Mzabi, Anis, et al.
Publicado: (2021)

Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus
por: Zhou, Zhuochao, et al.
Publicado: (2020)

Adult-Onset Still’s Disease: A Case Report and Review of Current Therapeutic Options
por: Thomas, Steffi, et al.
Publicado: (2022)

Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
por: Vercruysse, François, et al.
Publicado: (2019)

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kva1hmfdv9h1284g9129harqn2